DAT-1604

· Danatlas Pharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DAT-1604, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor [Phase 1]

See pricing